Camurus AB
Records under this name other than the patents Camurus AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 35 patents it holds.
Showing 1 to 9 of 9 · Back to Camurus AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,236,755 | Opioid depot formulations Term ended Term ended Jul 31, 2026 · From the USPTO record | Term ended | Term ended Jul 31, 2026 | From the USPTO record |
| US 9,649,382 | Topical bioadhesive formulations Term ended Term ended Jun 8, 2026 · From the USPTO record | Term ended | Term ended Jun 8, 2026 | From the USPTO record |
| US 9,968,680 | Topical bioadhesive formulations Term ended Term ended Mar 27, 2026 · From the USPTO record | Term ended | Term ended Mar 27, 2026 | From the USPTO record |
| US 8,187,629 | Non-lamellar compositions of DOPE and P80 Term ended Term ended Mar 3, 2026 · From the USPTO record | Term ended | Term ended Mar 3, 2026 | From the USPTO record |
| US 9,526,788 | Pharmaceutical lipid compositions Term ended Ended no later than Dec 9, 2025 · From the USPTO record | Term ended | Ended no later than Dec 9, 2025 | From the USPTO record |
| US 8,545,832 | Lipid depot formulations Term ended Ended no later than Jun 6, 2025 · From the USPTO record | Term ended | Ended no later than Jun 6, 2025 | From the USPTO record |
| US 6,599,517 | Bone tissue restoring composition Lapsed on the fee record Ended Jul 29, 2007 · From the USPTO record | Lapsed on the fee record | Ended Jul 29, 2007 | From the USPTO record |
| US 5,001,062 | Antithrombogenic article containing lysozyme and heparin adsorbed on a substrate Formerly held Term ended Term ended no later than Mar 19, 2011 · Low confidence | Term ended | Term ended no later than Mar 19, 2011 | Low confidence |
| US 5,260,282 | Saliva substitute Formerly held Term ended Term ended no later than Nov 9, 2013 · Low confidence | Term ended | Term ended no later than Nov 9, 2013 | Low confidence |